Progressive lawmakers are calling on President Joe Biden to take advantage of the fact that the U.S. Army’s new pan-coronavirus vaccine recipe is not restricted by intellectual property restrictions and share the information with the world.
According to the Army, early research shows that the Spike Ferritin Nanoparticle (SpFn) vaccine, developed by scientists at the Walter Reed Army Institute of Research, can “provide broad protection” against COVID-19 and future variants. The SpFn vaccine must still undergo Phase 2 and 3 of human trials, but if it proves successful, distributing the new vaccine around the globe could be a game-changer in the fight against the COVID pandemic.
Author(s): WALKER BRAGMAN, ANDREW PEREZ
Publication Date: 1 Feb 2022
Publication Site: Daily Poster